CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
4 Mar, 20:00
NYSE NYSE
$
80. 57
+0.08
+0.1%
$
96.93B Market Cap
11.4 P/E Ratio
0.97% Div Yield
5,374,644 Volume
7.87 Eps
$ 80.49
Previous Close
Day Range
79.67 81.09
Year Range
58.35 85.15
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS earnings report is expected in 55 days (29 Apr 2026)
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why

CVS Health (CVS) Stock Sinks As Market Gains: Here's Why

CVS Health (CVS) closed at $56.25 in the latest trading session, marking a -1.94% move from the prior day.

Zacks | 1 year ago
CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock

CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock

CVS Health faces outpatient and supplemental benefits pressure within Health Care Benefits.

Zacks | 1 year ago
CVS Health Stock Dip: Undervalued And Ready For A Turnaround

CVS Health Stock Dip: Undervalued And Ready For A Turnaround

CVS Health dropped ~10% following Q3 earnings, impacted by a $1.1B Medicare charge and a $1.2B restructuring charge. CVS's FY2024 EPS forecast is $6.47, down 26.01% YoY, reflecting financial challenges, but FY2025 recovery is projected at $7.30, up 13%. The company's revenue is estimated at $369.25 billion in 2024, with upward revisions suggesting optimism, projected to reach $386.28 billion by 2025.

Seekingalpha | 1 year ago
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
CVS's Karen Lynch was just ousted. Why women CEOs are 45% more likely to get fired than men.

CVS's Karen Lynch was just ousted. Why women CEOs are 45% more likely to get fired than men.

At the present rate, it will take 81 years to achieve gender parity among the CEO class

Marketwatch | 1 year ago
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks | 1 year ago
Under New CEO, Don't Look For Major CVS Health Breakup

Under New CEO, Don't Look For Major CVS Health Breakup

The new chief executive officer of CVS Health is schooled in many of the traditions that built the company into a major player in both health insurance and healthcare delivery. So don't look for David Joyner to move away from vertical integration as both a provider and a health insurance company.

Forbes | 1 year ago
CVS workers strike at 7 California locations seeking better pay, health care

CVS workers strike at 7 California locations seeking better pay, health care

Workers at seven CVS pharmacies in California are now on strike, seeking better pay and health care, as the stores remain open and staffed by managers and nonunion employees.

Foxbusiness | 1 year ago
2 "Safe" Healthcare Stocks That Are Anything But

2 "Safe" Healthcare Stocks That Are Anything But

If you buy these stocks, you might be in for serious disappointment when they underperform.

Fool | 1 year ago
CVS Stock Plummets as It Replaces CEO

CVS Stock Plummets as It Replaces CEO

CVS Health (CVS) stock tumbled about 5% in Friday after the pharmacy and healthcare giant announced the replacement of Chief Executive Officer (CEO) Karen Lynch with David Joyner, a longtime company veteran who most recently ran Caremark, its pharmacy benefit manager (PBM).

Investopedia | 1 year ago
CVS ousts Karen Lynch in CEO shakeup

CVS ousts Karen Lynch in CEO shakeup

CVS (CVS) has announced that it has replaced its CEO Karen Lynch with longtime executive David Joyner, sending shares sinking in Friday's trading session. Stephanie Davis, Barclays senior research analyst and managing director, joins Market Domination to discuss the leadership shakeup and what it means for CVS moving forward.

Youtube | 1 year ago
Deutsche Bank's George Hill talks CVS shares sinking on CEO shakeup

Deutsche Bank's George Hill talks CVS shares sinking on CEO shakeup

George Hill, Deutsche Bank managing director, joins 'Closing Bell Overtime' to talk CVS' C-Suite shakeup and what it means for the company.

Youtube | 1 year ago
Loading...
Load More